Mr Pritesh Jain
Keros Therapeutics, Lexington (United States of America)
RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.
Event: ESC Congress 2024
Topic: Biotherapies
Session: Biotherapies in cardiovascular disease: from bench to bedside
